Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Don’t Be Afraid to Engage: Health Technologies for Patients & Rheumatologists

Jason Liebowitz, MD, FACR  |  Issue: November 2024  |  September 24, 2024

With respect to the user-perceived experience, more than 12,000 people who had used this tool were surveyed in a study. Of these individuals, 78% found the tool useful, 76% felt the questionnaire allowed them to describe their complaints well and 74% would recommend the tool to friends and other patients.4

Dr. Grainger noted that such results for symptom checkers are encouraging. However, a key question that must be explored is: “How accurate are these tools?”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In a 2022 systematic review, Wallace et al. evaluated the accuracy of symptom checkers in yielding a diagnosis and appropriately guiding patient triage. They identified 10 studies that looked at a range of conditions, including inflammatory arthritis, ophthalmologic diseases and HIV. (Note: 50% of these studies recruited real patients, and the remainder used simulated cases). Among the tools studied, primary diagnostic accuracy (i.e., listing the correct diagnosis first) ranged from 19–38%, top three diagnostic accuracy (i.e., listing the correct diagnosis first, second or third) was 33–58% and overall triage accuracy (i.e., providing the correct triage advice) was 49–90%.5

In Dr. Grainger’s view, this study implies that symptom checkers show promise, but are not yet completely ready for primetime.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

With a plethora of potential technological interventions, rheumatologists must not neglect the elements of medicine that have always been important in caring for patients, such as attentive listening, empathy & the nuances of the physical examination.

Virtual Care

Dr. Grainger next discussed telehealth, which can take the form of telemedicine visits conducted by video and/or phone, remote monitoring of patients and online platforms designed to provide patient education and self-support tools.

Before the COVID-19 pandemic, telemedicine was in use, but this use was mostly via asynchronous means (i.e., sending an electronic message to a patient or calling them on the phone could be called telemedicine). Synchronous use was very limited and used primarily in rural and remote areas often with the purpose of extending the workforce—such as in Alaska.6

Dr. Grainger noted that telemedicine has several potential advantages, including improved access, decreased time and travel costs for patients, the ability to expand regional and remote care, and the reduction in infectious exposures for patients. At the same time, telemedicine has certain limitations, including potentially lower reimbursement, technological problems (i.e., hardware and software issues, access to Wi-Fi, ease of use and adoption among patients, etc.) and the inability to perform a full physical exam.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Meeting ReportsPractice SupportTechnology Tagged with:APLARAPLAR 2024appsAsia Pacific League of Associations for Rheumatology (APLAR)Personalized medicineTechnologytelehealthtelemedicine

Related Articles

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    The ACR Releases New Telemedicine Position Statement

    July 6, 2020

    The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

    Telemedicine & Fellowship Education After COVID-19: Q&A with Kanika Monga, MD

    July 14, 2020

    The COVID-19 pandemic is reshaping clinical rheumatology and the fellowship experience. Rheumatology education should include how to triage patients for remote visits, says second-year fellow Kanika Monga, MD…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences